Results for hirudin translation from Maltese to English

l- allerġija għal prodotti oħra ta’ hirudin huwa possibli.
cross-sensitivity to other hirudin products is possible.

antikorpi anti- hirudin kienu osservati ma ’ l- espożizzjoni mill- ġdid
anti-hirudin antibodies have been detected upon re-exposure

- jekk inti tbati minn sensittivita eċċessiva (allerġija) għal hirudin naturali jew sintetiku, inkluż
- if you are hypersensitive (allergic) to natural or synthetic hirudin, including desirudin or any of the

għandek ukoll tinforma lit-tabib tiegħek jekk qatt irċevejt revasc, hirudin jew derivattiv ta’hirudin.
you should also inform your doctor if you have ever received revasc, hirudin or an hirudin analogue.

għandek ukoll tgħid lit-tabib tiegħek jekk xi darba ħadt refludan, hirudin jew analogu ta’ hirudin.
you should also inform your doctor if you have ever received refludan, hirudin or a hirudin analogue.

lepirudin ([leu1, thr2]-63-desulfohirudin) huwa hirudin rikombinat derivat minn ċellolli tal-ħmira.
lepirudin ([leu1, thr2]-63-desulfohirudin) is a recombinant hirudin derived from yeast cells.

peress li dawn ir-reazzjonijiet huma ikkaġunati minn mekkaniżmi immunoloġiċi, pazjenti li diġà ħadu hirudin, jew analogu tiegħu, għandhom riskju miżjud.
as these reactions are immune-mediated, patients with previous exposure to hirudin or hirudin analogue may be at an increased risk.

hirudin naturali huwa prodott f’ammonti żgħar ħafna bħala familja ta’ iso-polipetids omologa ħafna minn sangisuga hirudo medicinalis.
natural hirudin is produced in trace amounts as a family of highly homologous iso-polypeptides by the leech hirudo medicinalis.

desirudin, is-sustanza attiva f’revasc, hija kważi identika għal hirudin, is-sustanza antikoagulanti prodotta mis-sangisugi.
desirudin, the active substance in revasc, is nearly identical to hirudin, the anticoagulant substance produced by leeches.

17 hirudin li dehru f’ ħafna mix- xadini kkurati wassal għal titwil tal- half- life terminali u żieda fl - espożizzjoni sistemika għal lepirudin.
antibodies against hirudin which appeared in several of the treated monkeys resulted in prolongation of the terminal half-life and an increase in systemic exposure to lepirudin.